The 12 closest competitors and alternatives to SIDERO BIOSCIENCE, LLC among biotechnology companies — ranked by similarity to what SIDERO BIOSCIENCE, LLC actually does, not by market-cap band.
Subscribe to see SIDERO BIOSCIENCE, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sidero Bioscience is a clinical-stage biotechnology company that develops natural iron supplement products to address iron deficiency and nutritional health. Its proprietary SideroSorb platform and BioFe iron complex utilize a unique uptake mechanism designed to improve absorption and minimize gastrointestinal side effects compared to traditional iron therapies.
SIDERO BIOSCIENCE, LLC is a biotechnology company headquartered in United States. Its most recent funding round raised $145,000 in October 2016. Xcout tracks 6 named people at SIDERO BIOSCIENCE, LLC, including Robert E. Harbaugh (Chief Operating Officer, Member of the Board of Directors).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $145,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to SIDERO BIOSCIENCE, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Ferrosa Therapeutics AG is a Swiss biotechnology company founded in Basel, Switzerland, focusing on developing novel therapeutics to treat anemia and related conditions.
Similar biotechnology company
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Biotech
Keros Therapeutics is a clinical-stage biopharmaceutical company that develops novel therapeutics targeting the transforming growth factor-beta (TGF-ß) superfamily of proteins. The company focuses on creating treatments for patients with hematological and neuromuscular disorders linked to dysfunctional protein signaling.
Similar biotechnology company
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Similar biotechnology company
Federation Bio is a U.S. biotechnology company developing live biotherapeutic products based on defined microbial communities to treat diseases. Its work has focused on microbiome-based therapies for metabolic and other serious disorders, serving patients with conditions that may benefit from engineered microbial consortia.
Biotech
Scarlet Therapeutics, founded in 2021 and headquartered in Bristol, United Kingdom, is developing a pioneering platform that generates novel red blood cell-based therapeutics to treat a wide range of diseases.
Similar biotechnology company
Solarea Bio, Inc. is a biotechnology company that develops solutions for health disorders using bacteria and fungi native to healthy foods.
Similar biotechnology company
Surface Oncology is a clinical-stage biotechnology company focused on developing immunotherapies that target the tumor microenvironment and enhance anti-tumor immune responses. Its programs are intended for cancer patients and are developed for use by oncology physicians and healthcare systems, with potential pharmaceutical partnerships.
Similar biotechnology company
Persephone Biosciences, Inc. is a synthetic biology company headquartered in San Diego, California. The company reimagines patient and infant health by developing clinically researched synbiotics derived from microbiome research.
Similar biotechnology company
AskBio is a clinical-stage gene therapy company that develops adeno-associated virus (AAV) gene therapies to treat genetic and complex disorders. The company focuses on advancing genetic medicine through its proprietary technology platforms, manufacturing processes, and clinical trials.
Similar biotechnology company
Adventa Bioscience Inc. is a biotech firm that develops health and wellness products based on human milk. Its flagship product, Trulacta, is a daily dietary supplement containing Human Milk Bionutrients designed to support gastrointestinal and whole-body health.
Similar biotechnology company
Curon Biopharmaceutical is a clinical-stage biotechnology company developing antibody-based medicines, including bispecific antibodies, for cancer and other serious diseases. It serves patients and healthcare providers through the development of therapeutic biologics, with programs intended for oncology and immunology applications.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for SIDERO BIOSCIENCE, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →